Literature DB >> 2917366

Five intermediate complexes in transcription initiation by RNA polymerase II.

S Buratowski1, S Hahn, L Guarente, P A Sharp.   

Abstract

A native gel electrophoresis DNA binding assay was used to resolve complexes formed on the adenovirus Major Late Promoter by general transcription factors and RNA polymerase II. Five sets of complexes containing distinct components were identified. These complexes were generated by sequential binding of TFIID, TFIIA, TFIIB, RNA polymerase II, and TFIIE. The relative positions of each of the factors in the complexes were determined by DNAase I footprint analysis. TFIIA, derived from yeast or mammalian cells, formed a complex with yeast TFIID and the TATA element. TFIIB bound to this complex and probably acts as a "bridge" to the polymerase and the initiation site. The addition of ATP or dATP, necessary for "activation" of transcription, resulted in an alteration of the footprint in the +20 to +30 region, the same area protected upon addition of TFIIE to the initiation complex. Addition of ribonucleotide triphosphates generated new complexes that contained accurately initiated transcripts associated with the transcription machinery and the template DNA. A model for the interactions of components in initiation of transcription by RNA polymerase II is proposed.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2917366     DOI: 10.1016/0092-8674(89)90578-3

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  399 in total

1.  Requirement for TAF(II)250 acetyltransferase activity in cell cycle progression.

Authors:  E L Dunphy; T Johnson; S S Auerbach; E H Wang
Journal:  Mol Cell Biol       Date:  2000-02       Impact factor: 4.272

2.  Characterization and functional analysis of Arabidopsis TFIIA reveal that the evolutionarily unconserved region of the large subunit has a transcription activation domain.

Authors:  Y F Li; J Le Gourierrec; M Torki; Y J Kim; F Guerineau; D X Zhou
Journal:  Plant Mol Biol       Date:  1999-02       Impact factor: 4.076

3.  Transcriptional repressor of vasoactive intestinal peptide receptor mediates repression through interactions with TFIIB and TFIIEbeta.

Authors:  L Pei
Journal:  Biochem J       Date:  2001-12-15       Impact factor: 3.857

4.  Genetic analysis of the large subunit of yeast transcription factor IIE reveals two regions with distinct functions.

Authors:  N H Kuldell; S Buratowski
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

5.  Evidence for the involvement of the Glc7-Reg1 phosphatase and the Snf1-Snf4 kinase in the regulation of INO1 transcription in Saccharomyces cerevisiae.

Authors:  M K Shirra; K M Arndt
Journal:  Genetics       Date:  1999-05       Impact factor: 4.562

6.  Herpes simplex virus type 1 ICP4 promotes transcription preinitiation complex formation by enhancing the binding of TFIID to DNA.

Authors:  B Grondin; N DeLuca
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

7.  TFIID and human mediator coactivator complexes assemble cooperatively on promoter DNA.

Authors:  Kristina M Johnson; Jin Wang; Andrea Smallwood; Charina Arayata; Michael Carey
Journal:  Genes Dev       Date:  2002-07-15       Impact factor: 11.361

8.  Mapping key functional sites within yeast TFIID.

Authors:  Claire Leurent; Steven L Sanders; Màté A Demény; Krassimira A Garbett; Christine Ruhlmann; P Anthony Weil; Làszlò Tora; Patrick Schultz
Journal:  EMBO J       Date:  2004-02-12       Impact factor: 11.598

9.  Amino acid substitutions in yeast TFIIF confer upstream shifts in transcription initiation and altered interaction with RNA polymerase II.

Authors:  Mohamed A Ghazy; Seth A Brodie; Michelle L Ammerman; Lynn M Ziegler; Alfred S Ponticelli
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

10.  Requirements for activation of the herpes simplex virus glycoprotein C promoter in vitro by the viral regulatory protein ICP4.

Authors:  B Gu; N DeLuca
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.